FDA committee backs approval of Sarepta Therapeutics’ SRP-9001 for DMD

Pallavi Madhiraju- May 13, 2023 0

Sarepta Therapeutics’ SRP-9001 (delandistrogene moxeparvovec) has received the backing of the Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) of the US Food and Drug ... Read More

PTC Therapeutics secures Russian approval for Translarna to treat Duchenne muscular dystrophy

pharmanewsdaily- December 6, 2020 0

PTC Therapeutics, a leading US-based biotechnology company, has received marketing approval in Russia for its innovative drug, Translarna (ataluren), designed to treat patients with Duchenne ... Read More

Astellas Pharma to acquire US gene therapy company Audentes Therapeutics

pharmanewsdaily- December 8, 2019 0

Astellas acquisition of Audentes: Japanese pharma company Astellas Pharma has agreed to acquire US gene therapy company Audentes Therapeutics in an all-cash deal worth about ... Read More

What is Muscular Dystrophy and Types of Muscular Dystrophy Explained

pharmanewsdaily- April 1, 2018 0

DailyHealthNeeds.com brings you the basic introduction to Muscular Dystrophy in simple easy to understand language. Find out about Muscular Dystrophy causes, Muscular Dystrophy symptoms and ... Read More

Exonics Therapeutics receives $5m seed funding to advance Duchenne Muscular Dystrophy therapy

pharmanewsdaily- February 28, 2017 0

Exonics Therapeutics, a biotechnology firm based in Boston, Massachusetts, has secured $5 million in seed funding from CureDuchenne Ventures, a subsidiary of the nonprofit Duchenne ... Read More

Pathological Conditions,Laboratory Tests and Clinical Procedures of Muscular System

pharmanewsdaily- December 25, 2013 0

Pathological conditions related to the muscular system are: Muscular dystrophy Polymyositis Muscular dystrophy: Muscular dystrophy is a group of inherited diseases characterized by progressive weakness ... Read More